Abhinav Kanwal

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Venues

Clinical rheumatology

Vaccines

Biomedicines

Expert review of clinical pharmacology

All India Institute of Medical Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

All India Institute of Medical Sciences Nov 08 2019

India

Assistant Professor :: Pharmacology

Manipal University Feb 15 2018 - Nov 06 2019

India

Assistant Professor :: Pharmacology

Publications

Nikhil Gupta, Navjot Kanwar, Anchal Arora, Kavin Khatri, Abhinav Kanwal
The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches. Clinical rheumatology 43 (5) (2024)
Nikhil Gupta, Navjot Kanwar, Anchal Arora, Kavin Khatri, Abhinav Kanwal
The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches. Clinical rheumatology 43 (5) (2024)
Nikhil Gupta, Navjot Kanwar, Anchal Arora, Kavin Khatri, Abhinav Kanwal
The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches. Clinical rheumatology (2024)
Nikhil Gupta, Navjot Kanwar, Anchal Arora, Kavin Khatri, Abhinav Kanwal
The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches. Clinical rheumatology 43 (5) (2024)
Puneetpal Singh, Nitin Kumar, Monica Singh, Manminder Kaur, Gurjinderpal Singh, Amit Narang, Abhinav Kanwal, Kirti Sharma, Baani Singh, Mario Di Napoli, Sarabjit Singh Mastana
Neutrophil Extracellular Traps and NLRP3 Inflammasome: A Disturbing Duo in Atherosclerosis, Inflammation and Atherothrombosis. Vaccines 11 (2) (2023)
Puneetpal Singh, Nitin Kumar, Monica Singh, Manminder Kaur, Gurjinderpal Singh, Amit Narang, Abhinav Kanwal, Kirti Sharma, Baani Singh, Mario Di Napoli, Sarabjit Singh Mastana
Neutrophil Extracellular Traps and NLRP3 Inflammasome: A Disturbing Duo in Atherosclerosis, Inflammation and Atherothrombosis. Vaccines 11 (2) (2023)
Abhinav Kanwal, Navjot Kanwar, Sanjay Bharati, Prateek Srivastava, Shailendra Pratap Singh, Salomon Amar
Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities. Biomedicines 10 (2) (2022)
Abhinav Kanwal
Functional and therapeutic potential of mitochondrial SIRT3 deacetylase in disease conditions. Expert review of clinical pharmacology 11 (12) (2018)

Abhinav Kanwal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Abhinav Kanwal